Antibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 67790-1-Ig - Provider product page

- Provider
- Proteintech Group
- Product name
- IFI16 antibody
- Antibody type
- Monoclonal
- Description
- IFI16 antibody (Cat. #67790-1-Ig) is a mouse monoclonal antibody that shows reactivity with Human and has been validated for the following applications: IHC, WB,ELISA.
- Reactivity
- Human
- Host
- Mouse
- Conjugate
- Unconjugated
- Isotype
- IgG
- Antibody clone number
- 1C10D7
- Vial size
- 20ul, 150ul
Submitted references Targeting leucine-rich repeat kinase 2 overcomes resistance to oncolytic herpes simplex virus-based therapies in glioblastoma.
G Protein-Coupled Receptor 30 Attenuates Neuronal Pyroptosis Induced by Subarachnoid Hemorrhage.
Deciphering lactate/lactylation networks in AML: integrated scRNA-seq and transcriptomics reveal functions and prognostic model.
IFI16 Induced by p53 Activates the NF-κB Pathway to Counteract Cisplatin-Induced Apoptosis in Cervical Cancer Cells.
IFI16 promotes the progression of clear cell renal cell carcinoma through the IL6/PI3K/AKT axis.
Qin Y, Liang Z, Yu M, Lin N, Wang N, Huang X, Chen S, Peng Q, Lin Y, Wang H, Rao Y, Xu Z, Huang S, Cai J, Li Y, Zhang J, Lin C, Tan G, Xia N, Huang C
Nature communications 2026 Feb 28;17(1)
Nature communications 2026 Feb 28;17(1)
G Protein-Coupled Receptor 30 Attenuates Neuronal Pyroptosis Induced by Subarachnoid Hemorrhage.
Peng J, Hu X, He J, Xia Y
Mediators of inflammation 2025;2025:3585885
Mediators of inflammation 2025;2025:3585885
Deciphering lactate/lactylation networks in AML: integrated scRNA-seq and transcriptomics reveal functions and prognostic model.
Chen X, Feng A, Guo H, Zeng J, Chen M
BMC cancer 2025 Oct 25;25(1):1647
BMC cancer 2025 Oct 25;25(1):1647
IFI16 Induced by p53 Activates the NF-κB Pathway to Counteract Cisplatin-Induced Apoptosis in Cervical Cancer Cells.
Zhong L, Li J, Zhong J, Zhang Y, Qi H, Yu H, Li X
Journal of cellular and molecular medicine 2025 Aug;29(15):e70728
Journal of cellular and molecular medicine 2025 Aug;29(15):e70728
IFI16 promotes the progression of clear cell renal cell carcinoma through the IL6/PI3K/AKT axis.
Lu K, Zhao Y, Li Y, Fu Z, Chen Y, Kong Y, Li G
Journal of translational medicine 2024 Jun 3;22(1):533
Journal of translational medicine 2024 Jun 3;22(1):533
No comments: Submit comment
No validations: Submit validation data